A version of the compromise budget deal for the remainder of this fiscal year has been released. This is the bill that the House and Senate are supposed to pass this week, and that President Obama must sign by Friday to prevent the Federal Government from shutting down. Originally, Republicans were aiming to cut the …
What’s going on with legislation on ES cell research in Minnesota? I blogged before about how Oklahoma legislators were heading toward passing legislation that would make it a crime to do ES cell research. Unfortunately, that legislation just passed. As if that were not bad enough, now potentially life saving research in Minnesota is starting …
Opponents of ES cell research launch stealth attack in Minnesota Read More »
What’s going on these days with biotech companies working on stem cell-based products? Geron’s and Advanced Cell Technology (ACT)’s FDA-approved trials presumably continue. As expected, no news yet. It’s too soon. Two important questions regarding both these companies are (1) did they apply for CIRM funding and (2) if so, how did the review process …
Stem cell biotech updates: Geron, ACT, Neuralstem, Pfizer Read More »
Reportedly, House Republicans are proposing a continuing resolution (CR) to fund the rest of FY2011 at 2008 funding levels. To achieve such an end, the Republicans would have to invoke serious cuts through the federal budget. Not only would such cuts likely damage the U.S. economy, but also they would have major other negative consequences. …
What makes stem cells different? The stem cell field is faced with a dilemma as stem cells and some non-stem cells are sometimes too similar to tell apart. Even worse, stem cells and cancer cells are especially similar. If one focuses specifically on cancer stem cells (aka tumor initiating cells), the similarity between cancer stem …